Yield Theory

Marjorie Taylor Greene · AMGN

Marjorie Taylor Greene's AMGN trades

Every Amgen Inc. transaction Marjorie Taylor Greene reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
4
Buys / sells
4 / 0
Disclosed range
$4K – $60K
Last filed
2025-10-28

AMGN transactions reported by Marjorie Taylor Greene

4 of 4 rows
TypeOwner
Amgen Inc. - Common Stock
AMGN
PurchaseSelf$1,001 - $15,0002025-10-28
#20033360
Amgen Inc. - Common Stock
AMGN
PurchaseSelf$1,001 - $15,0002025-09-27
#20032174
Amgen Inc. - Common Stock
AMGN
PurchaseSelf$1,001 - $15,0002025-05-19
#20030389
Amgen Inc. - Common Stock
AMGN
PurchaseSelf$1,001 - $15,0002025-05-06
#20030295

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Marjorie Taylor Greene and AMGN — questions

Did Marjorie Taylor Greene buy or sell AMGN?

House Clerk filings for 2025 and 2026 show 4 purchases and 0 sales of Amgen Inc. (AMGN) reported by Marjorie Taylor Greene, between 2025-05-05 and 2025-10-24. Reported owner: Self.

How much AMGN did Marjorie Taylor Greene trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K – $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last AMGN filing by Marjorie Taylor Greene?

The most recent periodic transaction report containing a AMGN row was filed on 2025-10-28. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Amgen Inc.. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Marjorie Taylor Greene AMGN disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included